Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function

Journal of Experimental Medicine

Volumn 210, Issue 11, 2013, Pages 2191-2204

  Nakamura, Atsushi ^a   Ebina Shibuya, Risa ^a   Itoh Nakadai, Ari ^a,b   Muto, Akihiko ^a,b   Shima, Hiroki ^a,b   Saigusa, Daisuke ^c   Aoki, Junken ^c   Ebina, Masahito ^a   Nukiwa, Toshihiro ^a   Igarashi, Kazuhiko ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; B LYMPHOID TRANSCRIPTION REPRESSOR BTB AND CNC HOMOLOGY 2 PROTEIN; CHOLESTEROL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 4; LUNG SURFACTANT; PROTEIN; PROTEIN YM1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHEMOTAXIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DYSPNEA; EOSINOPHIL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEMATOPOIETIC CELL; HEMATOPOIETIC SYSTEM; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID METABOLISM; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHOLESTEROL; DISEASE PROGRESSION; DYSPNEA; EOSINOPHILS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; INTERFERON REGULATORY FACTORS; LIPID METABOLISM; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE; PHAGOCYTOSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY SURFACTANTS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84886851330     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130028     Document Type: Article

References (64)

1. Ando, J., K. Tamayose, K. Sugimoto, and K. Oshimi. 2002. Late appearance of t(1;19)(q11;q11) in myelodysplastic syndrome associated with dysplastic eosinophilia and pulmonary alveolar proteinosis. Cancer Genet. Cytogenet. 139:14-17. http://dx.doi.org/10.1016/S0165-4608(02)00652-0
2. Baker, A.D., A. Malur, B.P. Barna, S. Ghosh, M.S. Kavuru, A.G. Malur, and M.J. Thomassen. 2010. Targeted PPARgamma deficiency in alveolarmacrophages disrupts surfactant catabolism. J. Lipid Res. 51:1325-1331. http://dx.doi.org/10.1194/jlr. M001651
3. Bates, S.R., J.Q. Tao, H.L. Collins, O.L. Francone, and G.H. Rothblat. 2005. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L980-L989. http://dx.doi.org/10.1152/ajplung.00234.2005
4. Blanchard, P.G., W.T. Festuccia, V.P. Houde, P. St-Pierre, S. Brûlé, V. Turcotte, M. Cóté, K. Bellmann, A. Marette, and Y. Deshaies. 2012. Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion. J. Lipid Res. 53:1117-1125. http://dx.doi.org/10.1194/jlr. M021485
5. Bonfield, T.L., C.F. Farver, B.P. Barna, A. Malur, S. Abraham, B. Raychaudhuri, M.S. Kavuru, and M.J. Thomassen. 2003. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 29:677-682. http://dx.doi.org/10.1165/rcmb.2003-0148OC
6. Borie, R., C. Danel, M.P. Debray, C. Taille, M.C. Dombret, M. Aubier, R. Epaud, and B. Crestani. 2011. Pulmonary alveolar proteinosis. Eur Respir Rev. 20:98-107. http://dx.doi.org/10.1183/09059180.00001311
7. Brügger, B., G. Erben, R. Sandhoff, F.T. Wieland, and W.D. Lehmann. 1997. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA. 94:2339-2344. http://dx.doi.org/10.1073/pnas.94.6.2339
8. Buechner, H.A., and A. Ansari. 1969. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis. Chest. 55:274-278. http://dx.doi.org/10.1378/chest.55.4.274
9. Cao, S., J. Liu, M. Chesi, P.L. Bergsagel, I.C. Ho, R.P. Donnelly, and X. Ma. 2002. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 169:5715-5725.
10. Chawla, A., W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtiss, et al. 2001. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7:161-171. http://dx.doi.org/10.1016/S1097-2765(01)00164-2
11. Cordonnier, C., J. Fleury-Feith, E. Escudier, K. Atassi, and J.F. Bernaudin. 1994. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am. J. Respir. Crit. Care Med. 149:788-794. http://dx.doi.org/10.1164/ajrccm.149.3.8118651
12. Corti, M., A.R. Brody, and J.H. Harrison. 1996. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14:309-315. http://dx.doi.org/10.1165/ajrcmb.14.4.8600933
13. Dirksen, U., R. Nishinakamura, P. Groneck, U. Hattenhorst, L. Nogee, R. Murray, and S. Burdach. 1997. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 100:2211-2217. http://dx.doi.org/10.1172/JCI119758
14. Dohi, Y., T. Ikura, Y. Hoshikawa, Y. Katoh, K. Ota, A. Nakanome, A. Muto, S. Omura, T. Ohta, A. Ito, et al. 2008. Bach1 inhibits oxidative stress-induced cellular senescence by impeding p53 function on chromatin. Nat. Struct. Mol. Biol. 15:1246-1254. http://dx.doi.org/10.1038/nsmb.1516
15. Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 264:713-716. http://dx.doi.org/10.1126/science.8171324
16. Fleetwood, A.J., T. Lawrence, J.A. Hamilton, and A.D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178:5245-5252.
17. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35. http://dx.doi.org/10.1038/nri978
18. Gunasekara, L., W.M. Schoel, S. Schürch, and M.W. Amrein. 2008. A comparative study of mechanisms of surfactant inhibition. Biochim. Biophys. Acta. 1778:433-444. http://dx.doi.org/10.1016/j.bbamem.2007.10.027
19. Harris, J.O. 1979. Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages. Chest. 76:156-159. http://dx.doi.org/10.1378/chest.76.2.156
20. Homer, R.J., T. Zheng, G. Chupp, S. He, Z. Zhu, Q. Chen, B. Ma, R.D. Hite, L.I. Gobran, S.A. Rooney, and J.A. Elias. 2002. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L52-L59.
21. Igarashi, K., K. Ochiai, and A. Muto. 2007. Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation. J. Biochem. 141:783-789. http://dx.doi.org/10.1093/jb/mvm106
22. Ikegami, M., J.A. Whitsett, Z.C. Chroneos, G.F. Ross, J.A. Reed, C.J. Bachurski, and A.H. Jobe. 2000. IL-4 increases surfactant and regulates metabolism in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L75-L80.
23. Inoue, Y., B.C. Trapnell, R. Tazawa, T. Arai, T. Takada, N. Hizawa, Y. Kasahara, K. Tatsumi, M. Hojo, T. Ichiwata, et al; Japanese Center of the Rare Lung Diseases Consortium. 2008. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am. J. Respir. Crit. Care Med. 177:752-762. http://dx.doi.org/10.1164/rccm.200708-1271OC
24. Ishii, H., R. Tazawa, C. Kaneko, T. Saraya, Y. Inoue, E. Hamano, Y. Kogure, K. Tomii, M. Terada, T. Takada, et al. 2011. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. Eur. Respir. J. 37:465-468. http://dx.doi.org/10.1183/09031936.00092910
25. Iyonaga, K., M. Suga, T. Yamamoto, H. Ichiyasu, H. Miyakawa, and M. Ando. 1999. Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis. Eur. Respir. J. 14:383-389. http://dx.doi.org/10.1034/j.1399-3003.1999.14b24.x
26. Kang, K., S.M. Reilly, V. Karabacak, M.R. Gangl, K. Fitzgerald, B. Hatano, and C.H. Lee. 2008. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 7:485-495. http://dx.doi.org/10.1016/j.cmet.2008.04.002
27. Keller, C.A., A. Frost, P.T. Cagle, and J.L. Abraham. 1995. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest. 108:277-280. http://dx.doi.org/10.1378/chest.108.1.277
28. Kitamura, T., N. Tanaka, J. Watanabe, S. Uchida, S. Kanegasaki, Y. Yamada, and K. Nakata. 1999. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190:875-880. http://dx.doi.org/10.1084/jem.190.6.875
29. Kohyama, M., W. Ise, B.T. Edelson, P.R. Wilker, K. Hildner, C. Mejia, W.A. Frazier, T.L. Murphy, and K.M. Murphy. 2009. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature. 457:318-321. http://dx.doi.org/10.1038/nature07472
30. Kuroki, Y., H. Takahashi, H. Chiba, and T. Akino. 1998. Surfactant proteins A and D: disease markers. Biochim. Biophys. Acta. 1408:334-345. http://dx.doi.org/10.1016/S0925-4439(98)00079-9
31. Ladeb, S., J. Fleury-Feith, E. Escudier, J. Tran Van Nhieu, J.F. Bernaudin, and C. Cordonnier. 1996. Secondary alveolar proteinosis in cancer patients. Support. Care Cancer. 4:420-426. http://dx.doi.org/10.1007/BF01880639
32. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11:750-761. http://dx.doi.org/10.1038/nri3088
33. Martinez, F.O. 2011. Regulators of macrophage activation. Eur. J. Immunol. 41:1531-1534. http://dx.doi.org/10.1002/eji.201141670
34. Matute-Bello, G., J.S. Lee, C.W. Frevert, W.C. Liles, S. Sutlief, K. Ballman, V. Wong, A. Selk, and T.R. Martin. 2004. Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice. J. Immunol. Methods. 292:25-34. http://dx.doi.org/10.1016/j.jim.2004.05.010
35. Mosser, D.M., and J.P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969. http://dx.doi.org/10.1038/nri2448
36. Muto, A., H. Hoshino, L. Madisen, N. Yanai, M. Obinata, H. Karasuyama, N. Hayashi, H. Nakauchi, M. Yamamoto, M. Groudine, and K. Igarashi. 1998. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3β enhancer. EMBO J. 17:5734-5743. http://dx.doi.org/10.1093/emboj/17.19.5734
37. Muto, A., S. Tashiro, O. Nakajima, H. Hoshino, S. Takahashi, E. Sakoda, D. Ikebe, M. Yamamoto, and K. Igarashi. 2004. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature. 429:566-571. http://dx.doi.org/10.1038/nature02596
38. Muto, A., K. Ochiai, Y. Kimura, A. Itoh-Nakadai, K.L. Calame, D. Ikebe, S. Tashiro, and K. Igarashi. 2010. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J. 29:4048-4061. http://dx.doi.org/10.1038/emboj.2010.257
39. Nelson, S.M., X. Lei, and K.S. Prabhu. 2011. Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages. J. Nutr. 141:1754-1761. http://dx.doi.org/10.3945/jn.111.141176
40. Nogee, L.M., D.E. de Mello, L.P. Dehner, and H.R. Colten. 1993. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N. Engl. J. Med. 328:406-410. http://dx.doi.org/10.1056/NEJM199302113280606
41. Nogee, L.M., A.E. Dunbar III, S.E. Wert, F. Askin, A. Hamvas, and J.A. Whitsett. 2001. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344:573-579. http://dx.doi.org/10.1056/NEJM200102223440805
42. Ochiai, K., Y. Katoh, T. Ikura, Y. Hoshikawa, T. Noda, H. Karasuyama, S. Tashiro, A. Muto, and K. Igarashi. 2006. Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells. J. Biol. Chem. 281:38226-38234. http://dx.doi.org/10.1074/jbc. M607592200
43. Odegaard, J.I., R.R. Ricardo-Gonzalez, M.H. Goforth, C.R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A.W. Ferrante, and A. Chawla. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 447:1116-1120. http://dx.doi.org/10.1038/nature05894
44. Oyake, T., K. Itoh, H. Motohashi, N. Hayashi, H. Hoshino, M. Nishizawa, M. Yamamoto, and K. Igarashi. 1996. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16:6083-6095.
45. Paine, R. III, S.B. Morris, H. Jin, S.E. Wilcoxen, S.M. Phare, B.B. Moore, M.J. Coffey, and G.B. Toews. 2001. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1210-L1218.
46. Perez-Gil, J., and T.E. Weaver. 2010. Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda). 25:132-141. http://dx.doi.org/10.1152/physiol.00006.2010
47. Postle, A.D., L.W. Gonzales, W. Bernhard, G.T. Clark, M.H. Godinez, R.I. Godinez, and P.L. Ballard. 2006. Lipidomics of cellular and secreted phospholipids from differentiated human fetal type II alveolar epithelial cells. J. Lipid Res. 47:1322-1331. http://dx.doi.org/10.1194/jlr. M600054-JLR200
48. Rauh, M.J., V. Ho, C. Pereira, A. Sham, L.M. Sly, V. Lam, L. Huxham, A.I. Minchinton, A. Mui, and G. Krystal. 2005. SHIP represses the generation of alternatively activated macrophages. Immunity. 23:361-374. http://dx.doi.org/10.1016/j.immuni.2005.09.003
49. Ricote, M., A.F. Valledor, and C.K. Glass. 2004. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24:230-239. http://dx.doi.org/10.1161/01.ATV.0000103951.67680.B1
50. Roychoudhuri, R., K. Hirahara, K. Mousavi, D. Clever, C.A. Klebanoff, M. Bonelli, G. Sciumè, H. Zare, G. Vahedi, B. Dema, et al. 2013. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature. 498:506-510. http://dx.doi.org/10.1038/nature12199
51. Ruben, F.L., and T.S. Talamo. 1986. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am. J. Med. 80:1187-1190. http://dx.doi.org/10.1016/0002-9343(86)90683-2
52. Saigusa, D., K. Shiba, A. Inoue, K. Hama, M. Okutani, N. Iida, M. Saito, K. Suzuki, T. Kaneko, N. Suzuki, et al. 2012. Simultaneous quantitation of sphingoid bases and their phosphates in biological samples by liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Bioanal. Chem. 403:1897-1905. http://dx.doi.org/10.1007/s00216-012-6004-9
53. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11:936-944. http://dx.doi.org/10.1038/ni.1920
54. Satoh, T., H. Kidoya, H. Naito, M. Yamamoto, N. Takemura, K. Nakagawa, Y. Yoshioka, E. Morii, N. Takakura, O. Takeuchi, and S. Akira. 2013. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature. 495:524-528. http://dx.doi.org/10.1038/nature11930
55. Sciammas, R., A.L. Shaffer, J.H. Schatz, H. Zhao, L.M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 25:225-236. http://dx.doi.org/10.1016/j.immuni.2006.07.009
56. Shapiro-Shelef, M., K.I. Lin, L.J. McHeyzer-Williams, J. Liao, M.G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 19:607-620. http://dx.doi.org/10.1016/S1074-7613(03)00267-X
57. Shibata, Y., P.Y. Berclaz, Z.C. Chroneos, M. Yoshida, J.A. Whitsett, and B.C. Trapnell. 2001. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 15:557-567. http://dx.doi.org/10.1016/S1074-7613(01)00218-7
58. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature. 380:627-630. http://dx.doi.org/10.1038/380627a0
59. Thomassen, M.J., B.P. Barna, A.G. Malur, T.L. Bonfield, C.F. Farver, A. Malur, H. Dalrymple, M.S. Kavuru, and M. Febbraio. 2007. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J. Lipid Res. 48:2762-2768. http://dx.doi.org/10.1194/jlr. P700022-JLR200
60. Trapnell, B.C., J.A. Whitsett, and K. Nakata. 2003. Pulmonary alveolar proteinosis. N. Engl. J. Med. 349:2527-2539. http://dx.doi.org/10.1056/NEJMra023226
61. Trapnell, B.C., B.C. Carey, K. Uchida, and T. Suzuki. 2009. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr. Opin. Immunol. 21:514-521. http://dx.doi.org/10.1016/j.coi.2009.09.004
62. Tsukumo, S., M. Unno, A. Muto, A. Takeuchi, K. Kometani, T. Kurosaki, K. Igarashi, and T. Saito. 2013. Bach2 maintains T cells in a naive state by suppressing effector memory-related genes. Proc. Natl. Acad. Sci. USA. 110:10735-10740. http://dx.doi.org/10.1073/pnas.1306691110
63. Wong, S.C., A.L. Puaux, M. Chittezhath, I. Shalova, T.S. Kajiji, X. Wang, J.P. Abastado, K.P. Lam, and S.K. Biswas. 2010. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol. 40:2296-2307. http://dx.doi.org/10.1002/eji.200940288
64. Yoshida, M., M. Ikegami, J.A. Reed, Z.C. Chroneos, and J.A. Whitsett. 2001. GM-CSF regulates protein and lipid catabolism by alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L379-L386.